A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
Clinical trial NCT06182969 · RECRUITING
Trial details
- NCT number
- NCT06182969
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-09
- Primary completion
- 2026-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.